BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
CNBC
MarketWatch
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.